Tower Research Capital LLC (Trc) Genocea Biosciences, Inc. Transaction History

Tower Research Capital LLC (Trc)

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.01 - $1.38 $58 - $8,068	-5,847 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$0.96 - $1.35 $202 - $284	-211 Reduced 3.48%	5,847 $7,000
Q4 2021 Feb 14, 2022	BUY	$0.95 - $1.99 $148 - $310	156 Added 2.64%	6,058 $7,000
Q3 2021 Nov 15, 2021	SELL	$1.74 - $2.33 $4,649 - $6,225	-2,672 Reduced 31.16%	5,902 $11,000
Q2 2021 Aug 16, 2021	SELL	$2.06 - $2.82 $675 - $924	-328 Reduced 3.68%	8,574 $20,000
Q1 2021 May 17, 2021	SELL	$2.35 - $4.01 $14,078 - $24,023	-5,991 Reduced 40.23%	8,902 $24,000
Q4 2020 Feb 16, 2021	BUY	$1.91 - $2.67 $25,572 - $35,748	13,389 Added 890.23%	14,893 $36,000
Q3 2020 Nov 16, 2020	BUY	$1.81 - $5.53 $2,722 - $8,317	1,504 New	1,504 $3,000
Q3 2019 Nov 05, 2019	SELL	$2.9 - $4.07 $3,088 - $4,334	-1,065 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$3.47 - $6.71 $3,695 - $7,146	1,065 New	1,065 $4,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.